Sanofi has said it plans to start discussions about filing its oral BTK inhibitor tolebrutinib for multiple sclerosis, even though the drug only achieved its primary objective in one of three phase 3 ...
Choose a SQL Server trial, edition, tool, or connector that best meets your data and workload needs. Accelerate AI development with SQL Server 2025, the AI-ready enterprise database with best-in-class ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results